Literature DB >> 21719358

Predictors of pulmonary complications after bariatric surgery.

Prateek K Gupta1, Himani Gupta, Manu Kaushik, Xiang Fang, Weldon J Miller, Lee E Morrow, R Armour-Forse.   

Abstract

BACKGROUND: Postoperative pneumonia (PP) and respiratory failure (PRF) are known to be the most common nonwound complications after bariatric surgery. Our objective was to identify their current prevalence after bariatric surgery and to study the preoperative factors associated with them using data from the American College of Surgeons' National Surgical Quality Improvement Program.
METHODS: Patients undergoing bariatric surgery were identified from the National Surgical Quality Improvement Program (2006-2008), a multicenter, prospective database. Univariate analysis and multivariate logistic regression analysis were performed.
RESULTS: Of 32,889 patients, PP was diagnosed in 187 patients (.6%) and PRF in 204 patients (.6%). The overall 30-day morbidity rate was 6.4%, with PP and PRF accounting for 18.7%. The 30-day mortality rate was greater for the patients with PP and PRF than those without (4.3% versus .16% and 13.7% versus .10%, P < .0001). The hospital length of stay was also longer in patients with PP/PRF (P < .0001). On multivariate analysis, congestive heart failure (odds ratio 5.3, 95% confidence interval 1.20-23.26) and stroke (odds ratio 4.1, 95% confidence interval 1.42-11.49) were the greatest preoperative risk factors for PP. Previous percutaneous coronary intervention (odds ratio 2.8, 95% confidence interval 1.64-4.74) and dyspnea at rest (odds ratio 2.64, 95% confidence interval 1.13-6.13) were the factors most strongly associated with PRF. Bleeding disorder, age, chronic obstructive pulmonary disease, and type of surgery were risk factors for both (P < .05). Smoking also predisposed to PP, and diabetes mellitus, anesthesia time, and increasing weight also predisposed to PRF (P < .05 for all).
CONCLUSION: Although PP and PRF are infrequent, they account for one fifth of the postoperative morbidity and are associated with significantly increased 30-day mortality. They can be predicted by various risk factors, emphasizing the importance of patient optimization and careful selection before bariatric surgery.
Copyright © 2012 American Society for Metabolic and Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21719358     DOI: 10.1016/j.soard.2011.04.227

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  14 in total

1.  Prediction of Airflow Obstruction and the Risk of Complications in Morbidly Obese Patients Undergoing Bariatric Surgery.

Authors:  Yasemin Türk; Harman K Singh; Astrid van Huisstede; Erwin Birnie; Ulas Biter; Pieter S Hiemstra; Gert-Jan Braunstahl
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

2.  What's new in postoperative intensive care after bariatric surgery?

Authors:  Philippe Montravers; Lara Ribeiro-Parenti; Camille Welsch
Journal:  Intensive Care Med       Date:  2015-02-12       Impact factor: 17.440

3.  Continuous administration of linezolid in pneumonia: what is the level of proof?

Authors:  Olivier Mimoz; Philippe Montravers; José-Artur Paiva
Journal:  Intensive Care Med       Date:  2014-11-26       Impact factor: 17.440

4.  Neostigmine Versus Sugammadex for Reversal of Neuromuscular Blockade and Effects on Reintubation for Respiratory Failure or Newly Initiated Noninvasive Ventilation: An Interrupted Time Series Design.

Authors:  Martin Krause; Shannon K McWilliams; Kenneth J Bullard; Lena M Mayes; Leslie C Jameson; Susan K Mikulich-Gilbertson; Ana Fernandez-Bustamante; Karsten Bartels
Journal:  Anesth Analg       Date:  2020-07       Impact factor: 5.108

5.  Pulmonary function testing and complications of laparoscopic bariatric surgery.

Authors:  Astrid van Huisstede; Laser Ulas Biter; Ronald Luitwieler; Manuel Castro Cabezas; Guido Mannaerts; Erwin Birnie; Christian Taube; Pieter S Hiemstra; Gert-Jan Braunstahl
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

6.  Do Changes in Perioperative and Postoperative Treatment Protocol Influence the Frequency of Pulmonary Complications? A Retrospective Analysis of Four Different Bariatric Groups.

Authors:  Mervi Hannele Javanainen; Tom Scheinin; Harri Mustonen; Marja Leivonen
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

7.  A Population-Based Study of Early Postoperative Outcomes in Patients with Heart Failure Undergoing Bariatric Surgery.

Authors:  Andrew T Strong; Gautam Sharma; Chao Tu; Ali Aminian; James B Young; John Rodriguez; Matthew Kroh
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

8.  Smoking in bariatric surgery: a systematic review.

Authors:  Alexandra Chow; Amy Neville; Nicole Kolozsvari
Journal:  Surg Endosc       Date:  2020-06-10       Impact factor: 4.584

9.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

10.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Endocr Pract       Date:  2013 Mar-Apr       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.